Minodronate Monohydrate
99%
- Product Code: 76874
CAS:
155648-60-5
| Molecular Weight: | 322.15(as Anhydrous) g./mol | Molecular Formula: | C₉H₁₂N₂O₇P₂H₂O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00890772 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature, dry |
Product Description:
Minodronate monohydrate is primarily used in the treatment of osteoporosis, particularly in postmenopausal women. It works by inhibiting bone resorption, thereby increasing bone density and reducing the risk of fractures. This medication is also effective in managing other conditions related to bone loss, such as Paget's disease and hypercalcemia associated with malignancy. It is typically administered orally and requires careful adherence to dosing instructions to maximize efficacy and minimize potential side effects. Regular monitoring of bone density and calcium levels is often recommended during treatment to assess progress and adjust therapy as needed.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to Light yellow to Light red powder to crystal |
| PURITY | 98.5-100 |
| WaterVaporization methoed | 4.8 % 5.8 % |
| Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | £35.96 |
+
-
|
| 0.500 | 10-20 days | £124.39 |
+
-
|
| 1.000 | 10-20 days | £230.24 |
+
-
|
Minodronate Monohydrate
Minodronate monohydrate is primarily used in the treatment of osteoporosis, particularly in postmenopausal women. It works by inhibiting bone resorption, thereby increasing bone density and reducing the risk of fractures. This medication is also effective in managing other conditions related to bone loss, such as Paget's disease and hypercalcemia associated with malignancy. It is typically administered orally and requires careful adherence to dosing instructions to maximize efficacy and minimize potential side effects. Regular monitoring of bone density and calcium levels is often recommended during treatment to assess progress and adjust therapy as needed.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :